Point72 Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$919K	Buy	194,264 +175,968	+962%	+$1.07M	﹤0.01%	2814
2025 Q4	$331K	Buy	+18,296	New	+$273K	﹤0.01%	3438
2023 Q4	–	Sell	-22,200	Closed	-$821K	–	2155
2023 Q3	$821K	Sell	22,200 -689	-3%	-$30.7K	﹤0.01%	1388
2023 Q2	$921K	Buy	22,889 +21,799	+2,000%	+$1.23M	﹤0.01%	1157
2023 Q1	$79K	Buy	+1,090	New	+$106K	﹤0.01%	1681
2022 Q4	–	Sell	-1,200	Closed	-$113K	–	1507
2022 Q3	$113K	Sell	1,200 -153,888	-99%	-$17.3M	﹤0.01%	1294
2022 Q2	$30.2M	Sell	155,088 -9,059	-6%	-$1.48M	0.13%	222
2022 Q1	$38.1M	Sell	164,147 -20,401	-11%	-$6.5M	0.15%	188
2021 Q4	$72.7M	Buy	184,548 +91,816	+99%	+$38.7M	0.29%	71
2021 Q3	$41.5M	Buy	92,732 +63,136	+213%	+$22.6M	0.18%	140
2021 Q2	$11.5M	Buy	29,596 +8,112	+38%	+$2.89M	0.05%	419
2021 Q1	$7.71M	Sell	21,484 -23,548	-52%	-$10.4M	0.04%	487
2020 Q4	$22.1M	Buy	+45,032	New	+$20.8M	0.11%	264
2020 Q3	–	Sell	-5,310	Closed	-$1.93M	–	917
2020 Q2	$1.93M	Buy	+5,310	New	+$1.34M	0.01%	596
2019 Q1	–	Sell	-22,124	Closed	-$19.2M	–	1009
2018 Q4	$19.2M	Buy	+22,124	New	+$20.5M	0.09%	269
2015 Q2	–	Sell	-1,004	Closed	-$1.04M	–	716
2015 Q1	$1.04M	Buy	+1,004	New	+$664K	0.01%	615